テキサスにおける脳腫瘍の臨床試験
テキサス内の拠点で、脳腫瘍に関する42件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
- Baylor St. Luke's Medical Center, Houston
被験者募集中第1相
21歳〜70歳 · 全性別 · 2026/09/30更新 · NCT06815432Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Baylor, Scott and White Research Institute, Dallas
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
- Mays Cancer Center, UT Health San Antonio, San Antonio
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07470606Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
- The University of Texas M. D. Anderson Cancer Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07053033A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
- M D Anderson Cancer Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT05048212A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0085, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07492680Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- MD Anderson Cancer Center, Houston
- START San Antonio, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT05786924Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center, Dallas
- Cook Children's Medical Center, Fort Worth
- Texas Children's Hospital, Houston
被験者募集中第2相
59 Months · 全性別 · 2026/09/15更新 · NCT05535166OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy
- MD Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07655583Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
- M D Anderson Cancer Center, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT04988009A Phase 1/1b Study of IAM1363 in HER2 Cancers
- NEXT Oncology - Austin, Austin
- Mary Crowley Cancer Research, Dallas
- MD Anderson Cancer Center - University of Texas, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06253871Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- University of Texas MD Anderson Cancer Center, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT05386108A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers
- MD Anderson Cancer Center, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/09更新 · NCT07467109A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- UT MD Anderson Cancer Center, Houston
- UT Health San Antonio Mays Cancer Center, San Antonio
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07428616Targeted Pediatric High-Grade Glioma Therapy
- Texas Children's Hospital, Houston
被験者募集中観察研究
12 Months – 39 Years · 全性別 · 2026/09/08更新 · NCT05839379HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- MD Anderson Cancer Center, Houston
被験者募集中第1相
36 Months – 22 Years · 全性別 · 2026/09/04更新 · NCT03911388Study of Olutasidenib and Temozolomide in HGG
- Texas Children's Hospital, Houston
被験者募集中第2相
12歳〜39歳 · 全性別 · 2026/09/01更新 · NCT06161974A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
- MD Anderson Cancer Center, Houston
- Community Clinical Trials, Kingwood
- Tranquil Clinical Research, Webster
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06764940A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
- Mary Crowley Cancer Research, Dallas
- The University of Texas M.D. Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06136884Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)
- Ut Southwestern Medical Center, Dallas
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/17更新 · NCT07139990Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
- Houston Methodist Neal Cancer Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/10更新 · NCT07383649Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
- Excel Diagnostics & Nuclear Oncology Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/07更新 · NCT07733674C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
- Texas Children's Hospital, Houston
被験者募集中第1相
12 Months – 25 Years · 全性別 · 2026/08/03更新 · NCT04099797Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- UT Southwestern Simmons Cancer Center, Dallas
- Baylor St. Luke's Medical Center | Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
- 他2件
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/22更新 · NCT04427384A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
- M D Anderson Cancer Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/16更新 · NCT05673928Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- M D Anderson Cancer Center, Houston
被験者募集中第1相
19歳以上 · 全性別 · 2026/07/16更新 · NCT03830151Mapping of Human Cognition
- The University of Texas Health Science Center at Houston, Houston
被験者募集中
18歳〜75歳 · 全性別 · 2026/07/14更新 · NCT05989893Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Texas Children's Hospital, Houston
被験者募集中第2相
12 Months – 39 Years · 全性別 · 2026/05/29更新 · NCT05843253Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
- M D Anderson Cancer Center, Houston
被験者募集中
18歳以上 · 全性別 · 2026/05/20更新 · NCT02754544A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
- M D Anderson Cancer Center, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/05/20更新 · NCT05342454Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
- M D Anderson Cancer Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/16更新 · NCT05064280EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active
- The University of Texas MD Anderson Cancer Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/15更新 · NCT06649058Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- MD Anderson Cancer Center, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06810544The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Md Anderson Cancer Center, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/05更新 · NCT04075305Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
- M D Anderson Cancer Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/05更新 · NCT05700721cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Elligo Health Research, Inc., Austin
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors
- MD Anderson Cancer Center, Houston
被験者募集中
15歳〜39歳 · 全性別 · 2026/01/09更新 · NCT06799481S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- UT Southwestern Clinical Center at Richardson/Plano, Richardson
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/08更新 · NCT03418961Systematic Light Exposure in Pediatric Brain Tumor Survivors
- Texas Children's Hospital, Houston
被験者募集中
10歳〜18歳 · 全性別 · 2025/09/18更新 · NCT05340881A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
- MD Anderson, Houston
- NEXT Oncology, San Antonio
被験者募集中第1/2相
18歳〜89歳 · 全性別 · 2025/08/19更新 · NCT06907043ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。